Market Capitalization

Facing sinking sales and credit downgrades, the appliance giant is swapping cheap, short-term debt for costly long-term security. A deep dive into a bold gambit.

Facing significant debt, Red Robin is selling 116 restaurants. Is this asset-light pivot a brilliant turnaround strategy or a risky financial maneuver?

Defiance just launched an ETF to short the newly public SpaceX. We dive into the high-stakes gamble on a trillion-dollar titan and the perilous tools of modern trading.

CrowdStrike's new Continuous Identity platform isn't just a product; it's a foundational shift for securing the coming wave of autonomous AI agents.

A Texas-based, private equity-backed firm just acquired a beloved local dermatology practice. It’s a story of national expansion, but what does it mean for care?

At VivaTech 2026, JCDecaux unveiled a bus shelter that fights heatwaves and AI-driven ads, blurring the line between public service and modern commerce.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

As AI's hunger for processing power outstrips supply, a new class of specialized cloud providers is emerging to challenge the giants. But can they deliver?

Anchorage Digital's custody of tokenized CETES marks a milestone, creating a federally regulated blueprint for bringing real-world sovereign debt onto the blockchain.

Greenland Resources is advancing its massive Malmbjerg molybdenum mine, a key EU project poised to slash reliance on China for critical steel and defense materials.

With a new $75M fund, Gutter Capital is doubling down on its 'old school' model: intense operational support for 'overlooked' founders in New York City.

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

Sumitomo Pharma's new data reveals a potent combination therapy for myelofibrosis and decodes resistance in leukemia, shaking up a competitive oncology landscape.

The crypto exchange touts democratized access to elite investments. But beneath the hype of Pre-IPO tokens lies a world of regulatory risk and unclear ownership.

A Brooklyn startup is using software to slash production times for a critical industrial part from months to weeks, signaling a major shift for US manufacturing.

Team Boxing League's new regional deal isn't just about sports; it's a calculated move in the high-stakes game of media disruption and audience capture.

QTREX Quantum's electronics 3D printing tech achieved 97% yield at a top US manufacturer, moving to the production floor. A quantum leap for electronics.

Facing a 'going concern' warning and collapsing revenue, Splash Beverage Group is ditching drinks for drugs. Its investment in Avicanna is a desperate, yet strategic, pivot.

With strategic hires from Robinhood and Raytheon, Hadrian signals a new phase in its mission to rebuild the U.S. defense industrial base with AI-powered factories.